What is the recommended treatment and dosage for sucralfate (sucralfate) in treating stomach and duodenal ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sucralfate Treatment for Stomach and Duodenal Ulcers

For treatment of duodenal ulcers, sucralfate should be administered at a dosage of 1 g four times per day on an empty stomach for 4-8 weeks. 1

Dosage Recommendations

Active Duodenal Ulcer

  • The recommended adult oral dosage is 1 g four times per day on an empty stomach 1
  • Treatment should continue for 4-8 weeks unless healing has been demonstrated by x-ray or endoscopic examination 1
  • Antacids may be prescribed for pain relief but should not be taken within 30 minutes before or after sucralfate 1

Gastric Ulcer

  • Although the FDA label doesn't specifically mention gastric ulcer dosing, clinical studies have shown that the same dosage of 1 g four times daily is effective for gastric ulcers 2
  • Healing rates for gastric ulcers are typically lower than for duodenal ulcers but comparable to those produced by other treatments 3

Maintenance Therapy

  • For preventing ulcer recurrence, the recommended adult oral dosage is 1 g twice a day 1
  • This maintenance dosage has been shown to reduce duodenal ulcer relapse rates from approximately 60% to 20% after 6 months 4

Special Populations

Elderly Patients

  • Dose selection for elderly patients should be cautious, usually starting at the lower end of the dosing range 1
  • This reflects the greater frequency of decreased hepatic, renal, or cardiac function, and potential drug interactions in elderly patients 1

Treatment Considerations

Efficacy

  • Sucralfate works by binding to proteinaceous material at the ulcer site, forming a protective barrier, neutralizing local acidity, inhibiting pepsin action, and adsorbing bile salts 3
  • Healing rates for duodenal ulcers with sucralfate are 75-85% after 4 weeks and 95-97% after 8 weeks of treatment 5

Place in Therapy

  • Proton pump inhibitors (PPIs) are generally considered first-line agents for treating and preventing gastrointestinal ulcers 6
  • Sucralfate is recommended as a second-line agent by the American College of Gastroenterology 6
  • For H. pylori-associated ulcers, eradication therapy should be used in addition to sucralfate 6

NSAID-Induced Ulcers

  • For NSAID-induced ulcers, discontinuation of NSAIDs is recommended when possible 6
  • If NSAIDs must be continued, adding a PPI for gastroprotection is preferred over sucralfate 7

Common Pitfalls and Caveats

  • Sucralfate should be taken on an empty stomach for maximum effectiveness 1
  • Absorption of other medications may be affected by sucralfate; therefore, other oral medications should be taken at least 30 minutes before or after sucralfate 3
  • Constipation is the most common side effect, occurring in approximately 2-4% of patients 3, 2
  • Testing for H. pylori infection should be performed in all patients with duodenal ulcer, as eradication therapy is necessary for H. pylori-positive patients 7
  • For stress ulcer prophylaxis in critically ill patients, PPIs or H2-receptor antagonists are typically preferred over sucralfate 6

References

Research

The efficacy, safety and dosage of sucralfate in ulcer therapy.

Scandinavian journal of gastroenterology. Supplement, 1987

Guideline

Sucralfate Treatment for Stomach and Duodenal Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duodenal Ulcer Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.